Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

The market for these drugs is expected to grow.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Hexahydrobenzo[f]quinolines are effective at blocking the enzyme 5α-reductase.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

5ARIs effectively treat and manage BPH by reducing prostate size and symptoms.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

The new compound may be a safer alternative to finasteride for prostate protection.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.